Therapeutic targeting strategies using endogenous cells and proteins
- 1 July 2017
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 258, 81-94
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horseCancer Nanotechnology, 2012
- Efficient In Vivo Delivery of siRNA Into Brain Capillary Endothelial Cells Along With Endogenous LipoproteinMolecular Therapy, 2011
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based MechanismsMolecular Therapy, 2010
- Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomasNanomedicine: Nanotechnology, Biology and Medicine, 2010
- Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis modelGene Therapy, 2008
- Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated plateletsBiomaterials, 2008
- Quantitative determination of total and unbound paclitaxel in human plasma following Abraxane treatmentJournal of Chromatography B, 2008
- Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancerInternational Journal of Cancer, 2004
- Exosomes: endosomal-derived vesicles shipping extracellular messagesCurrent Opinion in Cell Biology, 2004
- The Hallmarks of CancerCell, 2000